DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer.

DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer. Front Pharmacol. 2020; 11:1250.

View in: PubMed